A Study to Evaluate How Mirabegron Enters and Leaves the Bloodstream According to Age and Sex
Clinical trial NCT01285596 · COMPLETED
Trial details
- NCT number
- NCT01285596
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2009-11-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.